YAP (Yes-associated protein) regulates cell growth, tissue homeostasis, and organ size as a transcription co-activator in the Hippo tumor suppressor pathway. The kinase Lats inhibits YAP by phosphorylating it, causing it to localize to the cytoplasm and be degraded by proteasomes. By attaching to transcription factors from the TEAD family, YAP stimulates the expression of genes.
YAP has a complicated role in human cancer that may vary depending on the cell type. For instance, by inducing apoptosis in response to DNA damage, YAP may act as a tumor suppressor in some cell types, such as hematological cancers.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V85490 | VT02956 hydrochloride | ||
|
V147037 | VT101 | 65194-64-1 | VT101 is a TEAD inhibitor with an IC50 of 454 nM. |
|
V147038 | VT102 | 1119382-90-9 | VT102 is a TEAD1 inhibitor with a human IC50 value of 391 nM. |
|
V39633 | YAP-TEAD-IN-1 TFA | 1659305-79-9 | YAP-TEAD-IN-1 TFA is a potent competitive peptide inhibitor of YAP-TEAD interaction (IC50=25 nM). |
|
V69182 | YAP-TEAD-IN-2 | 2714432-83-2 | YAP-TEAD-IN-2 (compound 6) is a potent YAP-TEAD PPI (protein-protein interaction) inhibitor (antagonist) with IC50 of 2.7 nM. |
|
V85435 | YAP/TAZ inhibitor-3 | 2506273-81-8 | |
|
V93236 | YAP/TAZ inhibitor-4 | YAP/TAZ inhibitor-4 (compound 45) is a YAP/TAZ inhibitor that can inhibit TEAD transcriptional activation by inhibiting the binding of YAP or TAZ to TEAD. | |
|
V104453 | YAP/TAZ-TEAD-IN-2 | YAP/TAZ-TEAD-IN-2 (Compound 51) is a YAP/TAZ-TEAD inhibitor that inhibits the interaction between YAP/TAZ and TEAD. | |
|
V109075 | YAP/TAZ-TEAD-IN-3 | 2714434-41-8 | YAP/TAZ-TEAD-IN-3 is a YAP/TAZ-TEAD interaction inhibitor with an IC50 of 1.8 nM. |
|
V104967 | YAP/TEAD-IN-1 | YAP/TEAD-IN-1 (compound 4) is a potent YAP and TEAD inhibitor. | |
|
V147236 | YL-602 | 3081701-84-7 | YL-602 is an orally effective Hippo pathway activator. |
|
V73474 | YTP-17 | YTP-17 is an orally bioactive YAP-TEAD protein-protein interaction inhibitor (antagonist) with IC50 of 4 nM. |